Long-Term Effects of Fertility Treatments on Maternal Health

Background The long-term health effects of assisted reproductive technologies, including in vitro fertilization (IVF) and hormonal therapies, remain poorly understood. This highlights the need to investigate potential chronic conditions that may arise following treatment. Objective The objective of this study was to investigate the long-term effects of fertility treatments on maternal health, with a focus on the incidence of chronic conditions and overall health outcomes in women who have undergone such treatments. Methodology This cross-sectional study included 180 women, aged 20-45, who had received fertility treatments and successfully delivered a live child. The research was conducted at Rehman Medical Institute and Hayatabad Medical Complex in Peshawar, Pakistan, from January to December 2023. Data were collected through medical record reviews and structured interviews to assess long-term health outcomes, including cancer, metabolic disorders, and cardiovascular diseases. Descriptive statistics and logistic regression were applied using IBM SPSS Statistics for Windows, Version 25.0 (Released 2017; IBM Corp., Armonk, NY, USA), with a significance threshold set at p < 0.05. Results The study included 180 participants with an average age of 34.5 years. Among them, 73 (40.56%) underwent hormone therapy, 81 (45.00%) used IVF, and 26 (14.44%) used intracytoplasmic sperm injection. All participants delivered live births, with 21 (11.67%) experiencing premature deliveries and 33 (18.33%) having multiple pregnancies. Key findings showed that nine (5.00%) developed cancer, 31 (17.22%) had metabolic disorders, and 24 (13.33%) developed cardiovascular disease. Overall, 146 (81.11%) participants reported excellent long-term health, while 34 (18.89%) had new diagnoses, including 12 (6.67%) with cardiovascular disease, 18 (10.00%) with metabolic disorders, and four (2.22%) with cancer. Additionally, 36 (20.00%) had preeclampsia, 21 (12.00%) experienced OHSS, and 12 (7.00%) developed gestational diabetes. Conclusions Despite most participants reporting excellent overall health, the study underscores the need for ongoing monitoring and management, as it reveals significant long-term health risks associated with fertility treatments.

Authors

Institutions

Publication Details

Journal
Cureus
Published
2024-10-27
DOI
https://doi.org/10.7759/cureus.72464
Primary Topic
Assisted Reproductive Technology and Twin Pregnancy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Long-Term Effects of Fertility Treatments on Maternal Health

Faiza Rahman, Laraib Fatima, Hina Khan, Ayesha Khan et al.
Cureus
Assisted Reproductive Technology and Twin Pregnancy
article

Long-Term Effects of Fertility Treatments on Maternal Health

Faiza Rahman, Laraib Fatima, Hina Khan, Ayesha Khan, Nabila Shams, Laiba Asad, Kashmal Khattak
article en

Abstract

Background The long-term health effects of assisted reproductive technologies, including in vitro fertilization (IVF) and hormonal therapies, remain poorly understood. This highlights the need to investigate potential chronic conditions that may arise following treatment. Objective The objective of this study was to investigate the long-term effects of fertility treatments on maternal health, with a focus on the incidence of chronic conditions and overall health outcomes in women who have undergone such treatments. Methodology This cross-sectional study included 180 women, aged 20-45, who had received fertility treatments and successfully delivered a live child. The research was conducted at Rehman Medical Institute and Hayatabad Medical Complex in Peshawar, Pakistan, from January to December 2023. Data were collected through medical record reviews and structured interviews to assess long-term health outcomes, including cancer, metabolic disorders, and cardiovascular diseases. Descriptive statistics and logistic regression were applied using IBM SPSS Statistics for Windows, Version 25.0 (Released 2017; IBM Corp., Armonk, NY, USA), with a significance threshold set at p < 0.05. Results The study included 180 participants with an average age of 34.5 years. Among them, 73 (40.56%) underwent hormone therapy, 81 (45.00%) used IVF, and 26 (14.44%) used intracytoplasmic sperm injection. All participants delivered live births, with 21 (11.67%) experiencing premature deliveries and 33 (18.33%) having multiple pregnancies. Key findings showed that nine (5.00%) developed cancer, 31 (17.22%) had metabolic disorders, and 24 (13.33%) developed cardiovascular disease. Overall, 146 (81.11%) participants reported excellent long-term health, while 34 (18.89%) had new diagnoses, including 12 (6.67%) with cardiovascular disease, 18 (10.00%) with metabolic disorders, and four (2.22%) with cancer. Additionally, 36 (20.00%) had preeclampsia, 21 (12.00%) experienced OHSS, and 12 (7.00%) developed gestational diabetes. Conclusions Despite most participants reporting excellent overall health, the study underscores the need for ongoing monitoring and management, as it reveals significant long-term health risks associated with fertility treatments.

CureusVol. 16(10)
Hayatabad Medical Complex (PK)
Zero hunger
Openalex Percentile: Top 70%
Assisted Reproductive Technology and Twin Pregnancy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.